Search clinical trials for: Graft versus Host Disease
Total 389400 results
-
Sherif S. FaragCompletedHematopoietic Stem Cell Transplantation | Graft vs Host DiseaseUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedGraft Versus Host Disease (GVHD)United States
-
Baxalta now part of ShireKamada, Ltd.TerminatedGraft Versus Host DiseaseUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Cancer Prevention Research Institute of TexasCompletedLymphoma | LeukemiaUnited States
-
Kunming Pharmaceuticals, Inc.Unknown
-
Radboud University Medical CenterCompletedAllogeneic Stem Cell Transplant | Acute Myeloid Leucaemia | Myelo Dysplastic Syndrome | Acute Graft Versus Host Disease Grade II-IVNetherlands, Belgium
-
Karolinska InstitutetRegion StockholmTerminatedGraft-Versus-Host DiseaseSweden
-
Assistance Publique - Hôpitaux de ParisCompletedCyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT (ATG-CyGVHD)Graft vs Host DiseaseFrance
-
Nanfang Hospital of Southern Medical UniversityUnknownSteroid-refractory Gastrointestinal Acute Graft Versus Host DiseaseChina
-
Mehdi HamadaniCompletedAllogeneic Hematopoietic Stem Cell TransplantationUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Terminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnHematopoietic and Lymphoid Cell Neoplasm | Hematologic and Lymphocytic Disorder | Allogeneic Stem Cell Transplant RecipientUnited States
-
Astex Pharmaceuticals, Inc.TerminatedAcute Graft Versus Host DiseaseUnited States
-
Seoul National University HospitalTerminatedChronic Graft-versus-host DiseaseKorea, Republic of
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyCompletedLeukemia | Stem Cell TransplantationUnited States
-
Impatients N.V. trading as myTomorrowsKamada, Ltd.No longer availableAlpha 1-Antitrypsin Deficiency | Graft Vs Host Disease | Graft-versus-host-disease | Acute-graft-versus-host Disease | Steroid Refractory Acute Graft Versus Host Disease | Alpha-1 Proteinase Inhibitor | Alpha-1 Protease Inhibitor Deficiency | Acute Graft-Versus-Host Reaction Following Bone Marrow...
-
Peking University People's HospitalShanghai iCELL Biotechnology Co., Ltd, Shanghai, ChinaUnknownAcute-graft-versus-host DiseaseChina
-
Peking University People's HospitalUnknownAcute Graft-versus-host DiseaseChina
-
Peking University People's HospitalCompletedLeukemia, GVHD, ATG, TransplantationChina
-
Peking University People's HospitalCompletedStem Cell Transplantation | Graft Versus Host Disease | Poor Graft FunctionChina
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyTerminatedLymphoma | Leukemia | Myelodysplastic Syndrome | Hematological MalignanciesUnited States
-
Peking University People's HospitalCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedBronchiolitis Obliterans | Graft vs Host Disease | Constrictive Bronchiolitis | Bronchiolitis, Exudative | Bronchiolitis, ProliferativeUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedBronchiolitis Obliterans | Graft Versus Host Disease | Graft-Versus-Host Disease | Constructive Bronchiolitis | Bronchiolitis, Exudative | Bronchiolitis, ProliferativeUnited States
-
Duke UniversityCompletedAutoimmune Diseases | Chronic Graft Versus Host Disease | Sickle Cell DiseaseUnited States
-
Therakos, Inc., a Mallinckrodt CompanyTerminatedSteroid Refractory Acute Graft Versus Host DiseaseUnited States, Spain, France, Austria, Germany, Hungary, Italy, United Kingdom
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedMyelodysplastic Syndromes | Leukemia | Graft Versus Host DiseaseUnited States
-
Cynata Therapeutics LimitedCompletedGraft vs Host DiseaseAustralia, United Kingdom
-
Jonsson Comprehensive Cancer CenterWithdrawnLeukemia | Graft Versus Host Disease
-
Azienda Socio Sanitaria Territoriale degli Spedali...University of Turin, Italy; Università degli Studi di BresciaCompletedEndothelial Dysfunction | Graft Versus Host Disease, Acute | Immune ToleranceItaly
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedGraft Versus Host DiseaseUnited States
-
Dana-Farber Cancer InstituteCompletedChronic Versus Graft Host DiseaseUnited States
-
Mehrdad Abedi, MDMillennium Pharmaceuticals, Inc.CompletedGraft Versus Host DiseaseUnited States
-
University College, LondonUniversity College London HospitalsUnknownLupus Erythematosus, SystemicUnited Kingdom
-
Dana-Farber Cancer InstituteBiogenCompletedGraft Versus Host DiseaseUnited States
-
Stanford UniversityNovartisCompletedLymphoma, Non-Hodgkin | Lymphoma, T-Cell, Peripheral | Bone Marrow Transplant FailureUnited States, Canada
-
David MiklosNovartisCompletedGraft vs Host DiseaseUnited States
-
University of FreiburgCompletedGraft Versus Host Disease
-
Stanford UniversityCompletedGraft vs Host Disease | Blood and Marrow Transplant (BMT)United States
-
Universitätsklinikum Hamburg-EppendorfNovartis; Crolll GmbhCompletedChronic Graft-versus-host DiseaseGermany
-
National Cancer Institute (NCI)CompletedSclerotic Graft Versus Host Disease | Imatinib MesylateUnited States
-
Nelson ChaoNational Center for Advancing Translational Sciences (NCATS); Mereo BioPharmaWithdrawnHematologic MalignancyUnited States
-
National Cancer Institute (NCI)TerminatedGraft vs Host Disease | Graft-Versus-Host Disease | Chronic Graft vs. Host DiseaseUnited States
-
Central Hospital, Nancy, FranceCompleted
-
Rambam Health Care CampusWithdrawnFecal Microbiota Transplantation in Graft vs. Host DiseaseIsrael
-
Peking University People's HospitalUnknownAcute Leukemia | Allogeneic Hematopoietic Stem Cell Transplantation | Minimal Residual Disease | Relapse | Donor Lymphocyte Infusion | Graft-versus-host DiseaseChina
-
Children's Hospital Medical Center, CincinnatiTerminatedGraft Versus Host Disease (GVHD) | Diagnoses That Require Stem Cell TransplantUnited States
-
Mesoblast, Inc.No longer availableGraft vs Host Disease | Graft-Versus-Host DiseaseUnited States, Canada
-
Mesoblast, Inc.No longer availableGraft-Versus-Host DiseaseUnited States